QU BIOLOG INC has a total of 28 patent applications. Its first patent ever was published in 2005. It filed its patents most often in New Zealand, Japan and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, environmental technology and measurement are FAYAD JOSEPH M, ATRIVA THERAPEUTICS GMBH and JAFFE RUSSELL.
# | Country | Total Patents | |
---|---|---|---|
#1 | New Zealand | 6 | |
#2 | Japan | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 3 | |
#5 | Chile | 2 | |
#6 | China | 2 | |
#7 | Singapore | 2 | |
#8 | Australia | 1 | |
#9 | Brazil | 1 | |
#10 | Canada | 1 | |
#11 | Colombia | 1 | |
#12 | Republic of Korea | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Gunn Harold David | 26 |
#2 | Dhanji Salim | 12 |
#3 | Gunn Harold D | 2 |
#4 | Mullins David W | 2 |
Publication | Filing date | Title |
---|---|---|
WO2015164979A1 | Anti-microbial immunomodulation | |
US2013337012A1 | Tissue targeted antigenic activation of the immune response to treat cancers | |
NZ606490A | Immunogenic anti-inflammatory compositions | |
BR112013001794A2 | method for formulating an anti-inflammatory composition, for treating an individual, use of anti-inflammatory composition, method for formulating an immunogenic composition, method for treating a human patient, method for selecting an antigenic composition, selectively directing an immune response and method for buy answers, antigenic method the effectiveness of a treatment regimen | |
US2009074816A1 | Tissue targeted antigenic activation of the immune response to cancers | |
NZ601232A | Tissue targeted antigenic activation of the immune response to treat cancers |